Billy Evans, accomplice of Theranos founder Elizabeth Holmes, is engaged on a brand new startup that seeks to ship “human well being optimization” by means of blood testing, in response to The New York Occasions.
The Occasions reportedly spoke to 2 buyers pitched on the startup, known as Haemanthus, and in addition seen a few of Haemanthus’ advertising and marketing supplies.
In these supplies, the corporate says it has developed a machine that makes use of lasers to research blood, saliva, and urine samples to detect most cancers and infections. It reportedly plans to start out with pet well being earlier than increasing to people, and it seeks to boost greater than $50 million.
The pitch echoes that for Theranos, which promised to conduct quite a lot of medical exams on tiny quantities of blood drawn from pricked fingers. In 2022, Holmes (with whom Evans has two kids) was sentenced to 11 years in jail for defrauding buyers, although she mentioned in a latest interview that she stays “utterly dedicated to my dream of constructing inexpensive healthcare options out there to everybody.”
Early Fb investor Jim Breyer informed The Occasions that his crew was requested to speculate however declined “for lots of the similar causes we handed twice on Theranos.”
